Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MesoCancerVac by Amphera for Malignant Mesothelioma: Likelihood of Approval
MesoCancerVac is under clinical development by Amphera and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II...
Data Insights
MesoCancerVac by Amphera for Metastatic Pancreatic Cancer: Likelihood of Approval
MesoCancerVac is under clinical development by Amphera and currently in Phase I for Metastatic Pancreatic Cancer. According to GlobalData, Phase...